Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aminoacylase 1 pseudogene (LOC100418959; ENSG00000264236) is a non-functional, non-coding segment of DNA that arises from duplication or retrotransposition of the *aminoacylase 1* (ACY1) gene[1][3][5]. Unlike the ACY1 protein-coding gene, this pseudogene does not encode a functional enzyme and does not have a direct biological, pathological, or therapeutic role. Although pseudogenes can occasionally give rise to regulatory RNA transcripts (such as lncRNAs) or influence gene expression indirectly, no such function has been documented for this pseudogene[3][5]. In summary, ENSG00000264236 corresponds to an inactive genetic locus, not a therapeutic target or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aminoacylase 1 pseudogene.